Next Article in Journal
Clinical Characteristics and Predictors of Mortality in Critically Ill Adult Patients with Influenza Infection
Previous Article in Journal
A Scientometric Review of Urban Disaster Resilience Research
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 18
Issue 7
10.3390/ijerph18073680
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Midday Nap Duration and Hypertension among Middle-Aged and Older Chinese Adults: A Nationwide Retrospective Cohort Study

by
Jialin Fu
1,
Xinge Zhang
2,
Justin B. Moore
3,4,
Bowen Wang
1 and
Rui Li
5,*
1
Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, China
2
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
3
Department of Implementation Science, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
4
Department of Epidemiology & Prevention, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
5
Department of Health Management, School of Health Sciences, Wuhan University, Wuhan 430071, China
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(7), 3680; https://doi.org/10.3390/ijerph18073680
Submission received: 3 March 2021 / Revised: 30 March 2021 / Accepted: 31 March 2021 / Published: 1 April 2021
Browse Figure
Versions Notes

Abstract

:
The goal of this study was to investigate the associations of midday nap duration and change in midday nap duration with hypertension in a retrospective cohort using a nationwide representative sample of middle-aged and older Chinese adults. Data were obtained from the China Health and Retirement Longitudinal Study (CHARLS) database during 2011–2015. Information on midday nap duration was collected via a self-reported questionnaire and blood pressure was objectively measured. Hazard ratios (HR) with 95% confidence interval (CI) were estimated using Cox proportional hazards regression models to quantify the associations. A sample of 5729 Chinese adults (≥45 years old) were included in the longitudinal analysis. Relative to non-nappers, participants who napping for ≥90 min/day was associated with significantly larger HR for hypertension at four-year follow-up (HR = 1.18, 95% CI = 1.01–1.40, p = 0.048). Compared with people who napped ≥90 min/day both at baseline (2011) and follow-up (2013), hypertension risk at four-year follow-up declined in individuals whose midday nap durations decreased in the 2-year study period from ≥ 90 min/day to 1–59 min/day (HR = 0.59, 95% CI = 0.36–0.97, p = 0.037) and 60–89 min/day (HR = 0.68, 95% CI = 0.47–0.99, p = 0.044). Among middle-aged and older Chinese adults, relative to non-nappers, people who had longer midday nap duration (≥90 min/day) were associated with significantly larger HR for hypertension and decreased napping duration may confer benefit for hypertension prevention.

1. Introduction

High blood pressure is one of the most important risks for morbidity and mortality [1]. Many studies have identified high blood pressure as the best example of a surrogate measure for cardiovascular diseases, especially for stroke [2,3,4]. Hypertension, characterized by chronically elevated blood pressure above 140/90 mmHg, is one of the strongest risk factors of common cardiovascular diseases [5]. According to a study involving 200 countries, the number of adults with elevated blood pressure increased from 594 million in 1975 to 1.13 billion in 2015, comprising 597 million men and 529 million women [6]. High systolic blood pressure (SBP) was the leading risk factor of global disability-adjusted life-years (DALYs), and the cause of 10.4 million deaths and 218 million DALYs in 2017 [7]. In China, a nationwide survey completed in 2017 estimated that nearly half of the Chinese adults aged 35–75 years had hypertension [8]. Numerous studies have shown that age, gender, race/ethnicity [9], and lifestyle factors such as physical inactivity [10], high salt intake [5], obesity [11], and sleep duration [12] are risk factors for hypertension.
Napping is short sleep, typically taken during daylight hours. It is a prevalent lifestyle practice around the world, including China [13]. Some studies suggesting napping is beneficial to health by improving somatic functioning and working efficiency in the daytime [14] and counteracting sleep disorders (e.g., insomnia and sleep apnea) [15]. However, a growing number of studies reported adverse outcomes of daytime napping, such as increasing the odds of cardiovascular disease and all-cause mortality [16]. Daytime napping has been found associated with higher levels of inflammatory markers, such as C-reactive protein, in older adults [17]. As such, long daytime napping might increase risks of cardiovascular disease and all-cause mortality via chronic low-grade inflammation.
Previous studies have indicated the association between midday nap duration and hypertension, but the results were not consistent. Several studies have found that midday nap is associated with a greater risk of hypertension [18,19,20,21,22,23,24], while other studies have shown lower risk [25,26,27,28,29]. Currently, the existing literature regarding this issue lacks a high-quality prospective cohort study in China. More importantly, no study has yet examined the association between changes in nap duration and hypertension, which is important since sleep is a dynamic process over a lifetime [30]. Most epidemiological studies employed a single assessment of sleep information at one time, which limits the strength of observing any correlational relationships regarding sleep time change [31].
Thus, based on the CHARLS, a nationwide retrospective cohort study, we aimed to investigate the longitudinal association between midday naptime and hypertension among middle-aged and older Chinese adults.

2. Materials and Methods

2.1. Study Participants

Our research used data from the CHARLS, which was publicly available at http://charls.pku.edu.cn (accessed on 30 March 2021). CHARLS was a national representative investigation among 45-year-old or older Chinese adults. Participants from 450 villages or communities in 150 districts of 28 participating provinces were recruited using a stratified multistage probability-proportional-to-size random-cluster sampling strategy. The baseline survey was conducted to assess the social, economic, and health circumstances of community-residents in 2011 with a response rate of 80.5%. Respondents were periodically re-surveyed every two years using a face-to-face computer-assisted personal interview. The detailed methodology description and core questionnaire of the CHARLS have been described elsewhere [32]. The data used in this research were from the CHARLS 2011 baseline survey and follow-up in 2013 and 2015 and analyses were performed in 2020.
Out of a total of 17,708 respondents at baseline, 3743 subjects were excluded due to lack of data on blood pressure in the 2011 baseline survey, and 475 subjects were excluded due to missing data on baseline age, gender, height, weight, sleep duration, and midday napping in the 2011 baseline survey. An additional 5735 participants already diagnosed with hypertension at baseline were excluded from the longitudinal analysis. Similarly, 2026 subjects were excluded due to missing data on blood pressure at the four-year follow-up in 2015, resulting in a sample of 5729 adults who were included in the analysis of midday nap duration and the incident hypertension. We utilized data from this subsample of participants with complete data on midday napping with at least two visits (2011 and 2013) to assess the association between change in midday nap duration and hypertension risk in the subsequent 4 years (until the end of 2015). On the basis of the sample of analyzing the longitudinal association between midday nap duration and the incident hypertension, we excluded 464 subjects with missing data on midday napping in 2013, 5265 subjects were included in the analysis. (Figure 1)

2.2. Measurements of Sleep Duration and Hypertension

Midday nap duration was appraised using a self-reported questionnaire which asked, “During the past month, how long did you take a nap after lunch on average?” Sleep duration was assessed by the following question: “During the past month, how many hours of actual sleep did you get at night (average hours for one night)? This may be shorter than the number of hours you spend in bed.” These two questions had high validity and reliability for measuring the length of midday nap and night sleep [33,34].
Diastolic blood pressure (DBP) and SBP levels were measured using a mercury sphygmomanometer. Hypertension was diagnosed if an individual satisfied any of the four criteria: SBP ≥ 140 mmHg, DBP ≥ 90 mmHg, self-report of a diagnosis of hypertension, or currently taking antihypertensive medication [35]. Baseline hypertension was available from the baseline survey in 2011, and incident hypertension was defined as participants who were classified as having hypertension in either follow-up wave at four-year follow-up.

2.3. Potential Confounders

A structured questionnaire was used to collect information on sociodemographic characteristics (age, gender), and health-related variables including smoking status (current = 2, former = 1, or never = 0), drinking status (current = 2, former = 1, or never = 0), depression (yes = 1 or no = 0), and personal medical histories (hyperlipidemia and diabetes). BMI was objectively measured, calculated as the body weight in kilograms divided by height in meters squared (kg/m2). Depressive symptoms were assessed using the 10-item Center for Epidemiological Studies Depression Scale (CES-D-10), which has 10 questions with a scale of four points, and a cutoff score ≥ 10 was used to identify the respondents who had significant depressive symptoms [36]. Personal medical histories were appraised using the following questions: “Have you been diagnosed with hyperlipidemia by a doctor?” and “Have you been diagnosed with diabetes by a doctor?”.

2.4. Statistical Analyses

Baseline characteristics of participants were reported in strata of midday nap duration groups. Normality (Shapiro–Wilk test) and variances (Levene’s test) were performed. Data were compared using analysis of variance tests or Kruskal and Wallis test for continuous variables and χ2 analysis for categorical variables. Person-years for each subject were calculated from the date of recruitment until the date of the first hypertension event or the follow-up survey in 2015, whichever came first.
HR with 95% CI was estimated using Cox proportional hazards regression models with follow-up period as the time scale to assess the associations of baseline midday nap duration and changes in midday nap durations over two years with subsequent risks of hypertension. Age, gender, BMI, smoking status, drinking status, sleep duration, depressive mood, and personal medical histories (hyperlipidemia and diabetes) at baseline were included as potential confounders. For the purpose of analyzing the longitudinal association between midday nap duration and hypertension, following previous works, [22,24] we created five categories (0 min, 1–29 min, 30–59 min, 60–89 min, ≥90 min) according to the baseline (2011) midday napping, with the group who napped 0 min/day used as the reference group.
We used the changes of midday napping from baseline in 2011 to the first follow-up in 2013, as the exposure to evaluate the potential influence of change in midday nap duration on hypertension. As only 114 hypertension cases occurred in participants who had a midday nap less than 30 min, and 109 hypertension cases occurred in subjects who reported having a midday nap of 30–59 min, we combined 1–29 min and 30–59 min into 1–59 min, and divided midday napping into four groups (0 min, 1–59 min, 60–89 min, ≥90 min). The change in midday nap duration between the baseline survey (2011) and the first follow-up survey (2013) was coded through combinations of the four groups. Sixteen categories of change in midday nap duration were constructed and groups with the same midday nap duration categories at baseline (2011) and follow-up (2013) were used as the reference groups in our analysis.
All statistical analyses were performed using Stata version 16.0 (Stata Corp, College Station, TX, USA). All p-values were two-tailed, and p-values < 0.05 were considered statistically significant.

3. Results

Of 13,965 subjects with blood pressure at baseline, 5735 (41.07%) met the criteria for hypertension. Compared with normotensive individuals, the average duration of midday napping of subjects with hypertension was significantly longer (34.33 ± 0.58 min VS 31.46 ± 0.47 min, p < 0.001). Baseline characteristics of the longitudinal analysis categorized by midday nap duration are presented in Table 1. Among the 5729 participants included in the longitudinal analysis, 2839 (49.55%) individuals reported no napping, 495 (8.64%) participants had a midday nap less than 30 min, 485 (8.47%) subjects reported having a midday nap of 30–59 min, 1210 (21.12%) respondents reported a nap of 60–89 min/day and 700 (12.22%) had a midday nap equal to or longer than 90 min/day.
Table 2 below shows the associations between the midday nap duration and the risk of incident hypertension at four-year follow-up. The adjusted analysis shows that compared with participants who did not report napping, napping for ≥90 min/day was associated with significantly larger HR for hypertension (HR = 1.18, 95% CI = 1.01–1.40, p = 0.048).
We further conducted a stratified analysis by baseline characteristics. We observed a significantly larger risk of hypertension in individuals who reported both long sleep duration (≥8 h/night) and midday napping (≥90 min). We found that the association of hypertension with long midday nap duration (≥90 min/day) seemed to be more pronounced among participants who were overweight, or who either never smoke or drink, or without hyperlipidemia or diabetes. We also found that current-smokers who napped 1–30 min/day and ≥90 min/day were associated with a significantly larger risk of hypertension. In addition, the HR of developing hypertension at four-year follow-up for the older age subjects (≥60 years old) napped 60–89 min/day was 0.78 (Table A1).
Changes in midday nap duration from baseline (2011) and follow-up (2013) and the corresponding subsequent risk of hypertension in 2015 were presented in Table 3. Compared with people who napped ≥90 min/day both at baseline (2011) and follow-up (2013), after adjusting for confounders, we found significantly lower HR in people who decreased from ≥90 min/day at baseline (2011) to 1–59 min/day at follow-up (2013) (HR = 0.59, 95% CI = 0.36–0.97, p = 0.037) and to 60–89 min/day at follow-up (2013) (HR = 0.68, 95% CI = 0.47–0.99, p = 0.044).

4. Discussion

To our best knowledge, this is the first longitudinal cohort study to explore the association of midday nap duration and the change in midday nap duration with the risk of incident hypertension, using a nationwide representative sample of middle-aged and older Chinese adults. We found that, compared with participants without a habit of napping, long midday nap duration (≥90 min/day) was significantly associated with greater risks of hypertension at four-year follow-up. Compared with people who napped ≥90 min/day both at baseline (2011) and follow-up (2013), hypertension risks in 2015 was lower in middle-aged and older adults whose midday nap durations decreased in the 2-year study period from ≥90 min/day to 0–59 min/day and 60–89 min/day.
Previous studies have found that, relative to non-nappers, a higher prevalence of hypertension was found among people who frequently napped [18,19,20], and a meta-analysis conducted in 2016 found that the pooled RR (risk ratio) of hypertension in nappers was 1.13 [12], while some studies suggested that habitual napping was significantly associated with lower risk of hypertension [25,26]. Additionally, the associations between midday nap duration and hypertension were not consistent [21,22,23,24,27,28,29], especially in Chinese adults. Cai et al. found midday nap was significantly associated with a decreased prevalence of hypertension [27], and midday napping for more than 60 min was negatively associated with hypertension in Chinese adults living in rural areas [28,29]. However, a study including 13,469 Chinese adults over age 40 indicted, as compared to 0 min napping, all categories of daytime nap duration increased odds of incidence of hypertension [21]. Another cross-sectional study including 27,009 participants found that napping (≥30 min/day) was associated with a greater risk of hypertension among middle-aged and older Chinese [22]. In our analyses, among participants who napped 1–89 min/day, we found no significant association with hypertension, and lower HR for hypertension were observed in older age participants (≥60 years old) who napped 60–89 min/day. We also found longer midday nap duration (≥90 min/day) was associated with a significantly greater risk of hypertension, which is consistent with previous studies [22,23,24]. Additional large prospective studies are required to establish a clear relationship between midday nap duration and hypertension.
There are some plausible hypotheses that may help explain the relationship between midday napping and increased risk of hypertension. First, the morning has been recognized as the highest risk period of the day for cardiovascular events, with the surge in blood pressure caused by activation of the sympathetic nervous system [37]. Sympathetic surge also occurs when rising from a prolonged daytime nap resulting in rapid increases in blood pressure [38]. Second, midday napping could result in the elevation of evening cortisol levels [39], which may lead to high levels of blood pressure. Third, taking long napping may increases the total duration of sleep, and many studies have showed that longer sleep duration was associated with a greater risk of hypertension [40]. The findings of our study supported our speculation that we observed a significantly larger risk of hypertension in individuals who reported both long sleep duration (≥8 h/night) and midday napping (≥90 min). In addition, sleep apnea increases daytime and night-time blood pressure by neurogenic, hormonal, and vascular mechanisms and has been indicated as an important risk factor for hypertension [41]. Masa et al. demonstrated that people who with habitual midday nap having a greater frequency of sleep apnea [42], which may confound our observed relationships. Similarly, the association between midday nap and hypertension may be in part confounded by the indirect effect of midday nap on other diseases, such as diabetes and obesity. Several studies have indicated that midday nap is an important risk factor for diabetes and obesity in older adults [43,44]. Over two-thirds of type 2 diabetes patients were found with high blood pressure [45], and patients with obesity are more likely to report high blood pressure [46]. Notably, in our stratified analysis, longer midday nap duration (≥90 min/day) was found associated with significantly larger HR for hypertension in individuals with BMI ≥ 24, which was not observed among individuals with BMI < 24.
The current study, which utilized a retrospective cohort design, has the ability to investigate change in midday nap duration and subsequent risk of developing hypertension. We found that, compared with people who napped ≥90 min/day both at baseline (2011) and follow-up (2013), hypertension risk at four-year follow-up declined in middle-aged and older Chinese adults whose midday nap durations decreased in the 2-year study period from ≥90 min/day to 0–59 min/day and 60–89 min/day. Our findings suggest that people who had longer midday nap duration (≥90 min/day) but who decreased napping duration may experience a lower risk of developing hypertension. However, more research using objective measures of midday nap duration and blood pressure is required to further test the association.
The major strengths of our research lie in our utilization of a prospective cohort study to capture a nationally representative sample of middle-and older-age Chinese adults. This is the first cohort study that has evaluated the relationship between change in midday nap duration and hypertension. Besides, blood pressure was measured objectively and not self-reported in our research. Our study also has several limitations. First, measurement of midday nap duration and some health status indicators, such as smoking, drinking, depression, and personal medical histories, were based on self-reports and not objectively measured, which may lead to misclassification of exposure. Self-reported sleep duration estimated is usually longer than sleep duration from actigraphy or polysomnography [47]. Second, although we have adjusted for several factors that might confound the relationship between midday nap and hypertension, some confounders (such as salt intake, physical activity, sleep quality, obstructive sleep apnea) were not captured in our research [5,10,48,49]. Third, the survey in our study item asked specifically about napping after lunch, so we might miss some people who nap in the morning or evening. Fourth, this study was based on a population among middle-aged and older Chinese adults, our findings may not be applicable to populations in other countries.

5. Conclusions

This study provides evidence that longer midday nap duration (≥90 min/day) was significantly associated with larger risks of incident hypertension, and hypertension risk declined in whose midday napping decreased to 1–59 min/day. Considering that midday nap is a common modifiable behavior and hypertension is one of the strongest risk factors for common cardiovascular diseases worldwide, our findings offer information that can be used to make health-benefiting practical changes to prevent hypertension in the daily routines of individuals, especially in middle-aged and older Chinese adults. However, large, prospective longitudinal studies based on objective measures (such as actigraphy) of midday nap duration are needed to test the associations of midday nap duration and change in midday nap duration with hypertension among middle-aged and older Chinese adults. Additionally, the possible mechanisms behind the association need to be explored.

Author Contributions

Conceptualization, J.F., X.Z. and R.L.; methodology, J.F., X.Z., J.B.M. and R.L.; software, J.F. and X.Z.; validation, J.F. and B.W.; formal analysis, J.F. and X.Z.; resources, R.L.; data curation, J.F.; writing—original draft preparation, J.F.; writing—review and editing, X.Z., J.B.M., and R.L.; supervision, R.L.; project administration, R.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding

Acknowledgments

We are grateful to the CHARLS research team and all participants for their contribution. We also thank Wenjia Liu from the University of Washington (Seattle) for proofreading the manuscript.

Conflicts of Interest

The authors declare that there is no conflict of interest.

Appendix A

Table
Table A1. Hypertension risk and midday napping, stratified by baseline characteristics.
Table A1. Hypertension risk and midday napping, stratified by baseline characteristics.
Variables0 min (N = 2839)1–29 min (N = 495)30–59 min (N = 485)60–89 min (N = 1210)≥90 min (N = 700)
Person-YearsAdjusted HRPerson-YearsAdjusted HR
(95% CI)		Person-YearsAdjusted HR
(95% CI)		Person-YearsAdjusted HR
(95% CI)		Person-YearsAdjusted HR
(95% CI)
Age (years)
45–6070901.00 (ref.)11441.23 (0.93–1.61)11841.19 (0.90–1.57)29001.01 (0.82–1.24)15461.17 (0.92–1.50)
≥6036261.00 (ref.)6901.01 (0.76–1.34)6341.00 (0.75–1.35)16920.78 (0.62–0.97) *10241.18 (0.94–1.48)
Gender
Male51841.00 (ref.)9401.14 (0.87–1.49)8081.19 (0.89–1.59)22400.95 (0.77–1.17)11581.19 (0.93–1.52)
Female55321.00 (ref.)8941.09 (0.82–1.45)10101.03 (0.78–1.36)23520.85 (0.68–1.05)14121.18 (0.94–1.48)
BMI (kg/m2)
<2474741.00 (ref.)11701.09 (0.85–1.40)12421.01 (0.78–1.31)29660.85 (0.70–1.02)16141.10 (0.89–1.37)
≥ 2432421.00 (ref.)6641.17 (0.85–1.60)5761.25 (0.90–1.72)16260.97 (0.76–1.24)9561.31 (1.01–1.71) *
Sleep duration (hours)
≤655821.00 (ref.)8840.94 (0.70–1.26)9601.04 (0.79–1.38)21340.86 (0.69–1.06)10241.08 (0.83–1.40)
6–820341.00 (ref.)4081.32 (0.88–1.97)3760.90 (0.56–1.46)10400.86 (0.62–1.20)5041.28 (0.89–1.83)
≥831001.00 (ref.)5421.32 (0.93–1.89)4821.34 (0.92–1.94)14181.00 (0.76–1.32)10421.35 (1.02–1.78) *
Smoking
Current30941.00 (ref.)5601.54 (1.12–2.11) **4841.18 (0.81–1.71)15741.10 (0.86–1.41)9921.34 (1.02–1.75) *
Former6021.00 (ref.)1520.81 (0.38–1.75)1201.43 (0.73–2.83)4741.09 (0.69–1.73)2461.23 (0.70–2.14)
Never70201.00 (ref.)11221.15 (0.88–1.49)12141.01 (0.76–1.33)25440.92 (0.75–1.13)13321.27 (1.01–1.60) *
Drinking
Current31161.00 (ref.)6601.22 (0.89–1.66)5901.15 (0.82–1.61)17740.93 (0.73–1.18)10501.14 (0.87–1.49)
Former6381.00 (ref.)940.49 (0.15–1.60)1421.37 (0.73–2.57)3220.75 (0.42–1.34)1981.09 (0.59–1.98)
Never69621.00 (ref.)10801.16 (0.89–1.50)10861.02 (0.77–1.34)24960.91 (0.74–1.11)13221.30 (1.03–1.64) *
Depression
Yes52201.00 (ref.)8081.11 (0.82–1.50)8900.96 (0.70–1.31)20540.82 (0.65–1.04)11661.18 (0.92–1.52)
No54961.00 (ref.)10261.13 (0.87–1.47)9281.18 (0.91–1.55)25380.94 (0.78–1.15)14041.17 (0.93–1.46)
Hyperlipidemia
Yes4081.00 (ref.)1120.88 (0.35–2.23)1040.49 (0.14–1.67)2440.79 (0.37–1.68)1761.30 (0.64–2.61)
No10,3081.00 (ref.)17221.14 (0.94–1.40)13741.14 (0.93–1.39)45920.91 (0.78–1.06)32601.20 (1.01–1.42) *
Diabetes
Yes2921.00 (ref.)480.46 (0.11–1.95)1000.82 (0.35–1.91)1880.65 (0.33–1.30)1040.82 (0.35–1.94)
No10,4241.00 (ref.)17861.15 (0.94–1.40)17181.11 (0.90–1.37)44040.90 (0.77–1.05)24661.19 (1.00–1.41) *
Note: Adjusted for age, gender, BMI, smoking status (current, former, or never), drinking status (current, former, or never), sleep duration, depression (yes or no), hyperlipidemia (yes or no), and diabetes (yes or no). Each group adjusted for the other covariates. * p < 0.05, ** p < 0.01.

References

  1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360, 1903. [Google Scholar] [CrossRef]
  2. Lassere, M.N.; Johnson, K.R.; Schiff, M.; Rees, D. Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES). BMC Med. Res. Methodol. 2012, 12, 1–21. [Google Scholar] [CrossRef] [Green Version]
  3. Wagner, J.; Ball, J. Implications of the institute of medicine report: Evaluation of biomarkers and surrogate endpoints in chronic disease. Clin. Pharmacol. Ther. 2015, 98, 12–15. [Google Scholar] [CrossRef] [PubMed]
  4. Desai, M.; Stockbridge, N.; Temple, R. Blood pressure as an example of a biomarker that functions as a surrogate. AAPS J. 2006, 8, E146–E152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Poulter, N.R.; Prabhakaran, D.; Caulfield, M. Hypertension. Lancet 2015, 386, 801–812. [Google Scholar] [CrossRef]
  6. Zhou, B.; Bentham, J.; Di Cesare, M.; Bixby, H.; Danaei, G.; Cowan, M.J.; Paciorek, C.J.; Singh, G.; Hajifathalian, K.; Bennett, J.E.; et al. Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 2017, 389, 37–55. [Google Scholar] [CrossRef] [Green Version]
  7. GBD 2017 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study Lancet 2018, 392, 1923–1994. [CrossRef] [Green Version]
  8. Lu, J.; Lu, Y.; Wang, X.; Li, X.; Linderman, G.C.; Wu, C.; Cheng, X.; Mu, L.; Zhang, H.; Liu, J.; et al. Prevalence, awareness, treatment, and control of hypertension in China: Data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet 2017, 390, 2549–2558. [Google Scholar] [CrossRef]
  9. Staessen, J.A.; Wang, J.; Bianchi, G.; Birkenhäger, W.H. Essential hypertension. Lancet 2003, 361, 1629–1641. [Google Scholar] [CrossRef]
  10. Liu, X.; Zhang, D.; Liu, Y.; Sun, X.; Han, C.; Wang, B.; Ren, Y.; Zhou, J.; Zhao, Y.; Shi, Y.; et al. Dose–Response Association Between Physical Activity and Incident Hypertension. Hypertensionaha 2017, 69, 813–820. [Google Scholar] [CrossRef]
  11. Seravalle, G.; Grassi, G. Obesity and hypertension. Pharmacol. Res. 2017, 122, 1–7. [Google Scholar] [CrossRef] [PubMed]
  12. Cheungpasitporn, W.; Thongprayoon, C.; Srivali, N.; Vijayvargiya, P.; Andersen, C.A.; Kittanamongkolchai, W.; Sathick, I.J.J.; Caples, S.M.; Erickson, S.B. The effects of napping on the risk of hypertension: A systematic review and meta-analysis. J. Evid. Based Med. 2016, 9, 205–212. [Google Scholar] [CrossRef] [PubMed]
  13. Lan, T.-Y.; Lan, T.-H.; Wen, C.-P.; Lin, M.Y.-H.; Chuang, M.Y.-L. Nighttime Sleep, Chinese Afternoon Nap, and Mortality in the Elderly. Sleep 2007, 30, 1105–1110. [Google Scholar] [CrossRef] [Green Version]
  14. Milner, C.E.; Cote, K.A. Benefits of napping in healthy adults: Impact of nap length, time of day, age, and experience with napping. J. Sleep Res. 2009, 18, 272–281. [Google Scholar] [CrossRef] [PubMed]
  15. Faraut, B.; Andrillon, T.; Vecchierini, M.-F.; Leger, D. Napping: A public health issue. From epidemiological to laboratory studies. Sleep Med. Rev. 2017, 35, 85–100. [Google Scholar] [CrossRef] [PubMed]
  16. Yamada, T.; Hara, K.; Shojima, N.; Yamauchi, T.; Kadowaki, T. Daytime Napping and the Risk of Cardiovascular Disease and All-Cause Mortality: A Prospective Study and Dose-Response Meta-Analysis. Sleep 2015, 38, 1945–1953. [Google Scholar] [CrossRef]
  17. Leng, Y.; Ahmadi-Abhari, S.; Wainwright, N.W.J.; Cappuccio, F.P.; Surtees, P.G.; Luben, R.; Brayne, C.; Khaw, K.-T. Daytime napping, sleep duration and serum C reactive protein: A population-based cohort study. BMJ Open 2014, 4, e006071. [Google Scholar] [CrossRef]
  18. Tanabe, N.; Iso, H.; Seki, N.; Suzuki, H.; Yatsuya, H.; Toyoshima, H.; Tamakoshi, A.; JACC Study Group. Daytime napping and mortality, with a special reference to cardiovascular disease: The JACC study. Int. J. Epidemiol. 2009, 39, 233–243. [Google Scholar] [CrossRef] [Green Version]
  19. Léger, D.; Torres, M.J.; Bayon, V.; Hercberg, S.; Galan, P.; Chennaoui, M.; Andreeva, V.A. The association between physical and mental chronic conditions and napping. Sci. Rep. 2019, 9, 1–7. [Google Scholar] [CrossRef] [PubMed]
  20. Wang, C.; Bangdiwala, S.; Rangarajan, S.; Lear, S.; Alhabib, K.F.; Mohan, V.; Teo, K.; Poirier, P.; Tse, L.A.; Liu, Z.; et al. Association of estimated sleep duration and naps with mortality and cardiovascular events: A study of 116 632 people from 21 countries. Eur. Heart J. 2019, 40, 1620–1629. [Google Scholar] [CrossRef]
  21. Zhou, J.; Kessler, A.S.; Su, D. Association between Daytime Napping and Chronic Diseases in China. Am. J. Health Behav. 2016, 40, 182–193. [Google Scholar] [CrossRef]
  22. Cao, Z.; Shen, L.; Wu, J.; Yang, H.; Fang, W.; Chen, W.; Yuan, J.; Wang, Y.; Liang, Y.; Wu, T. The effects of midday nap duration on the risk of hypertension in a middle-aged and older Chinese population. J. Hypertens. 2014, 32, 1993–1998. [Google Scholar] [CrossRef]
  23. Lin, M.; Su, Q.; Wen, J.; Wei, S.; Yao, J.; Huang, H.; Liang, J.; Li, L.; Lin, W.; Lin, L.; et al. Self-reported sleep duration and daytime napping are associated with renal hyperfiltration in general population. Sleep Breath. 2017, 22, 223–232. [Google Scholar] [CrossRef]
  24. Yang, Y.; Liu, W.; Ji, X.; Ma, C.; Wang, X.; Li, K.; Li, J. Extended afternoon naps are associated with hypertension in women but not in men. Heart Lung 2020, 49, 2–9. [Google Scholar] [CrossRef]
  25. Zhao, H.; Gui, W.; Huang, H.; Liu, Y.; Ding, H.; Fan, W.; Huang, S.; Yang, W.; Wang, X.; Chen, G. Association of long-term sleep habits and hypertension: A cross-sectional study in Chinese adults. J. Hum. Hypertens. 2019, 34, 378–387. [Google Scholar] [CrossRef]
  26. Cao, Y.M.; Li, D.; Li, K.B.; Yu, H.; Xin, W.; Miao, D.J.; An, Y. Epidemiological study on the relationship between the siesta and blood pressure. Zhonghua yi Xue Za Zhi 2016, 96, 1699–1701. [Google Scholar] [PubMed]
  27. Cai, M.; Huang, Y.; Sun, X.; He, Y.; Sun, C. Siesta is associated with reduced systolic blood pressure level and decreased prevalence of hypertension in older adults. J. Hum. Hypertens. 2015, 30, 216–218. [Google Scholar] [CrossRef] [PubMed]
  28. Huang, M.; Yang, Y.; Huang, Z.; Yuan, H.; Lu, Y. The association of nighttime sleep duration and daytime napping duration with hypertension in Chinese rural areas: A population-based study. J. Hum. Hypertens. 2020, 1–7. [Google Scholar] [CrossRef]
  29. Wu, L.; He, Y.; Jiang, B.; Liu, M.; Wang, J.; Zhang, D.; Wang, Y.; Zeng, J.; Yao, Y. Association between sleep duration and the prevalence of hypertension in an elderly rural population of China. Sleep Med. 2016, 27–28, 92–98. [Google Scholar] [CrossRef] [PubMed]
  30. Zomers, M.L.; Hulsegge, G.; Van Oostrom, S.H.; Proper, K.I.; Verschuren, W.M.M.; Picavet, H.S.J. Characterizing Adult Sleep Behavior Over 20 Years—The Population-Based Doetinchem Cohort Study. Sleep 2017, 40, 40. [Google Scholar] [CrossRef] [PubMed]
  31. Gangwisch, J.E. A Review of Evidence for the Link between Sleep Duration and Hypertension. Am. J. Hypertens. 2014, 27, 1235–1242. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Zhao, Y.; Hu, Y.; Smith, J.P.; Strauss, J.; Yang, G. Cohort Profile: The China Health and Retirement Longitudinal Study (CHARLS). Int. J. Epidemiol. 2014, 43, 61–68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Li, Y.; Wu, Y.; Zhai, L.; Wang, T.; Sun, Y.; Zhang, D. Longitudinal Association of Sleep Duration with Depressive Symptoms among Middle-aged and Older Chinese. Sci. Rep. 2017, 7, 1–7. [Google Scholar] [CrossRef]
  34. Li, J.; Cacchione, P.Z.; Hodgson, N.; Riegel, B.; Ms, B.T.K.; Scharf, M.T.; Richards, K.C.; Gooneratne, N.S. Afternoon Napping and Cognition in Chinese Older Adults: Findings from the China Health and Retirement Longitudinal Study Baseline Assessment. J. Am. Geriatr. Soc. 2017, 65, 373–380. [Google Scholar] [CrossRef] [PubMed]
  35. Mancia, G.; Fagard, R.; Narkiewicz, K.; Redón, J.; Zanchetti, A.; Böhm, M.; Christiaens, T.; Cifkova, R.; De Backer, G.; Dominiczak, A.; et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. J. Hypertens. 2013, 31, 1281–1357. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Andresen, E.M.; Malmgren, J.A.; Carter, W.B.; Patrick, D.L. Screening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D. Am. J. Prev. Med. 1994, 10, 77–84. [Google Scholar] [CrossRef]
  37. Head, G.; Lukoshkova, E.V. Understanding the Morning Rise in Blood Pressure. Clin. Exp. Pharmacol. Physiol. 2008, 35, 516–521. [Google Scholar] [CrossRef]
  38. Stergiou, G.S.; Mastorantonakis, S.E.; Roussias, L.G. Intraindividual Reproducibility of Blood Pressure Surge upon Rising after Nighttime Sleep and Siesta. Hypertens. Res. 2008, 31, 1859–1864. [Google Scholar] [CrossRef] [Green Version]
  39. Woods, D.L.; Kim, H.; Yefimova, M. To Nap or Not to Nap. Biol. Res. Nurs. 2011, 15, 185–190. [Google Scholar] [CrossRef]
  40. Wang, Y.; Mei, H.; Jiang, Y.-R.; Sun, W.-Q.; Song, Y.-J.; Liu, S.-J.; Jiang, F. Relationship between Duration of Sleep and Hypertension in Adults: A Meta-Analysis. J. Clin. Sleep Med. 2015, 11, 1047–1056. [Google Scholar] [CrossRef]
  41. Floras, J.S. Hypertension and Sleep Apnea. Can. J. Cardiol. 2015, 31, 889–897. [Google Scholar] [CrossRef] [PubMed]
  42. Masa, J.F.; Rubio, M.; Pérez, P.; Mota, M.; De Cos, J.S.; Montserrat, J.M. Association between Habitual Naps and Sleep Apnea. Sleep 2006, 29, 1463–1468. [Google Scholar] [CrossRef] [PubMed]
  43. Patel, S.R.; Osteoporotic Fractures in Men for the Osteoporotic Fractures in Men (MrOS) and the Study of Osteoporotic Fractures (SOF) Research Groups; Hayes, A.L.; Blackwell, T.; Evans, D.S.; Ancoli-Israel, S.; Wing, Y.K.; Stone, K.L. The association between sleep patterns and obesity in older adults. Int. J. Obes. 2014, 38, 1159–1164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Fang, W.; Li, Z.; Wu, L.; Cao, Z.; Liang, Y.; Yang, H.; Wang, Y.; Wu, T. Longer habitual afternoon napping is associated with a higher risk for impaired fasting plasma glucose and diabetes mellitus in older adults: Results from the Dongfeng–Tongji cohort of retired workers. Sleep Med. 2013, 14, 950–954. [Google Scholar] [CrossRef] [PubMed]
  45. Ferrannini, E.; Cushman, W.C. Diabetes and hypertension: The bad companions. Lancet 2012, 380, 601–610. [Google Scholar] [CrossRef]
  46. Eckel, N.; Meidtner, K.; Kalle-Uhlmann, T.; Stefan, N.; Schulze, M.B. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 2016, 23, 956–966. [Google Scholar] [CrossRef]
  47. Lauderdale, D.S.; Knutson, K.L.; Yan, L.L.; Liu, K.; Rathouz, P.J. Self-Reported and Measured Sleep Duration. Epidemiology 2008, 19, 838–845. [Google Scholar] [CrossRef] [Green Version]
  48. St-Onge, M.-P.; Grandner, M.A.; Brown, D.; Conroy, M.B.; Jean-Louis, G.; Coons, M.; Bhatt, D.L. Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association. Circulation 2016, 134, e367–e386. [Google Scholar] [CrossRef] [Green Version]
  49. Loredo, J.S.; Ancoli-Israel, S.; Dimsdale, J.E. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am. J. Hypertens. 2001, 14, 887–892. [Google Scholar] [CrossRef]
Ijerph 18 03680 g001 550
Figure 1. Flow chart of participants.
Figure 1. Flow chart of participants.
Ijerph 18 03680 g001
Table
Table 1. Baseline characteristics of participants by midday nap duration groups (N = 5729).
Table 1. Baseline characteristics of participants by midday nap duration groups (N = 5729).
Variables0 min
(N = 2839)		1–29 min
(N = 495)		30–59 min
(N = 485)		60–89 min
(N = 1210)		≥90 min
(N = 700)		p Value 3
Age (years) 156.50 (13.00) 57.50 (12.00)56.50 (12.00)56.50 (14.00)57.50 (15.00)0.027
Gender 2 0.175
Male1372 (48.33)251 (50.71)219 (45.15)595 (49.17)315 (45.00)
Female1467 (51.67)244 (49.29)266 (54.85)615 (50.83)385 (55.00)
BMI (kg/m2) 122.32 (4.22)22.92 (4.60)22.49 (4.49)22.84 (4.57) 22.74(4.76) <0.001
Smoking status 2 <0.001
Current815 (28.71)158 (31.92)130 (26.80)421 (34.79)276 (39.43)
Former162 (5.71)40 (8.08)33 (6.80)126 (10.41)67 (9.57)
Never1862 (65.59)297 (60.00)322 (66.39)663 (54.79)357 (51.00)
Drinking status 2 <0.001
Current828 (29.17)178 (35.96)158 (32.58)473 (39.09)289 (41.29)
Former171 (6.02)25 (5.05)38 (7.84)84 (6.94)55 (7.86)
Never1840 (64.81)292 (58.99)289 (59.59)653 (53.97)356 (50.86)
SBP (mmHg) 1118.33 (17.67)119.33 (17.00)118.00 (18.00)117.67 (17.00)119.00 (17.67)0.229
DBP (mmHg) 170.33 (12.33)71.33 (12.00)70.67 (13.33)69.67 (12.67)71.00 (12.33)0.039
Sleep duration (h) 16.00 (3.00) 7.00 (3.00) 6.00 (3.00)7.00 (2.00)7.00 (2.00)<0.001
Depression 21380 (48.61)220 (44.44)233 (48.04)540 (44.63)317 (45.29)0.091
Comorbidities 2
Hyperlipidemia109 (3.84)31 (6.26)27 (5.57)62 (5.12)48 (6.86)0.004
Diabetes80 (2.82)13 (2.63)26 (5.36)49 (4.05)28 (4.00)0.019
1 Data are Median (IOR, interquartile range) for continuous variables (Shapiro-Wilk normality tests, p < 0.05). 2 Data are the frequency with percentage for categorical variables. 3 p Values were derived from analysis of Kruskal and Wallis tests for continuous variables and χ2 tests for category variables.
Table
Table 2. Hypertension risk between 2011–2015 follow-up across categories of midday napping at baseline.
Table 2. Hypertension risk between 2011–2015 follow-up across categories of midday napping at baseline.
Midday Napping,
Minutes		Cases/NPerson-YearsUnadjusted HR
(95% CI) 1		p ValueAdjusted HR
(95% CI) 2		p Value
0 min600/283910,7161.00 (ref.) 1.00 (ref.)
1–29 min121/49518341.18 (0.97–1.43)0.1011.12 (0.92–1.36)0.260
30–59 min113/48518181.11 (0.91–1.36)0.3091.10 (0.90–1.34)0.366
60–89 min244/121045920.95 (0.82–1.10)0.4920.89 (0.77–1.04)0.133
≥90 min185/70025701.28 (1.09–1.51)0.0031.18 (1.01–1.40)0.048
1 Pseudo R2 = 0.009. 2 Adjusted for age, gender, BMI, smoking status (current, former, or never), drinking status (current, former, or never), sleep duration, depression (yes or no), hyperlipidemia (yes or no) and diabetes (yes or no); Pseudo R2 = 0.036.
Table
Table 3. Hypertension risk by subcategories of midday napping across baseline (2011) and follow-up (2013).
Table 3. Hypertension risk by subcategories of midday napping across baseline (2011) and follow-up (2013).
Midday Napping, MinutesCases/NPerson-
Years		Unadjusted HR
(95% CI)		p ValueAdjusted HR
(95% CI) 1		p Value
20112013
0 min0 min389/175265761.00 (ref.) 2 1.00 (ref.) 6
1–59 min61/28710800.95 (0.73–1.25)0.7380.95 (0.72–1.24)0.701
60–89 min81/34112741.07 (0.85–1.37)0.5561.00 (0.79–1.28)0.973
≥90 min36/2158200.74 (0.53–1.05)0.0880.73 (0.52–1.03)0.073
1–59 min0 min60/2459021.04 (0.73–1.47)0.8281.08 (0.76–1.53)0.673
1–59 min68/28510641.00 (ref.) 3 1.00 (ref.) 7
60–89 min56/2208261.06 (0.75–1.51)0.7410.98 (0.69–1.40)0.920
≥90 min39/1405061.20 (0.81–1.78)0.361.13 (0.76–1.68)0.551
60–89 min0 min56/2569621.11 (0.79–1.57)0.5441.18 (0.83–1.67)0.359
1–59 min42/2298740.92 (0.63–1.34)0.660.97 (0.66–1.42)0.867
60–89 min75/38014341.00 (ref.) 4 1.00 (ref.) 8
≥90 min58/2409061.22 (0.87–1.72)0.2481.14 (0.80–1.61)0.470
≥90 min0 min25/1083960.72 (0.46–1.12)0.1450.77 (0.49–1.20)0.251
1–59 min19/1023840.57 (0.35–0.93)0.0250.59 (0.36–0.97)0.037
60–89 min40/1846900.66 (0.46–0.96)0.0310.68 (0.47–0.99)0.044
≥90 min89/28110101.00 (ref.) 5 1.00 (ref.) 9
1 Adjusted for age, gender, BMI, smoking status (current, former, or never), drinking status (current, former, or never), sleep duration, depression (yes or no), hyperlipidemia (yes or no) and diabetes (yes or no). 2 Pseudo R2 = 0.007; 3 Pseudo R2 = 0.010; 4 Pseudo R2 = 0.009; 5 Pseudo R2 = 0.007; 6 Pseudo R2 = 0.019; 7 Pseudo R2 = 0.031; 8 Pseudo R2 = 0.026; 9 Pseudo R2 = 0.021.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Fu, J.; Zhang, X.; Moore, J.B.; Wang, B.; Li, R. Midday Nap Duration and Hypertension among Middle-Aged and Older Chinese Adults: A Nationwide Retrospective Cohort Study. Int. J. Environ. Res. Public Health 2021, 18, 3680. https://doi.org/10.3390/ijerph18073680

AMA Style

Fu J, Zhang X, Moore JB, Wang B, Li R. Midday Nap Duration and Hypertension among Middle-Aged and Older Chinese Adults: A Nationwide Retrospective Cohort Study. International Journal of Environmental Research and Public Health. 2021; 18(7):3680. https://doi.org/10.3390/ijerph18073680

Chicago/Turabian Style

Fu, Jialin, Xinge Zhang, Justin B. Moore, Bowen Wang, and Rui Li. 2021. "Midday Nap Duration and Hypertension among Middle-Aged and Older Chinese Adults: A Nationwide Retrospective Cohort Study" International Journal of Environmental Research and Public Health 18, no. 7: 3680. https://doi.org/10.3390/ijerph18073680

APA Style

Fu, J., Zhang, X., Moore, J. B., Wang, B., & Li, R. (2021). Midday Nap Duration and Hypertension among Middle-Aged and Older Chinese Adults: A Nationwide Retrospective Cohort Study. International Journal of Environmental Research and Public Health, 18(7), 3680. https://doi.org/10.3390/ijerph18073680

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop